Clay Hoerig
Assistant Professor & Associate Program Director, Division of Pediatric Hematology/Oncology · University of Minnesota
Credentials: · · · ·
History
- Present
Division of Pediatric Hematology/Oncology · University of Minnesota
- Present
- 2019–2022
Research
Exploring the role and clinical implications of proteasome inhibition in medulloblastoma
Review · Pediatric Blood & Cancer · 2021 · First of 5 authors · 3 citations
Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma
PLoS ONE · 2024 · 3 citations
Cutaneous Manifestations in an Infant With Hemophagocytic Lymphohistiocytosis: Case Report
Case report · Journal of Pediatric Hematology/Oncology Nursing · 2025
3 papers
2 papers
- SM
2 papers
1 paper
- MP
1 paper
1 paper
1 paper
- RC
1 paper
Clinical trials
- 2022–2027
NF-1, Nutraceutical Intervention
Principal investigator · Active not recruiting · Phase 1
Masonic Cancer Center, University of Minnesota
- 2024–2033
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Site PI · Recruiting · Phase 2
Children's Oncology Group
- 2020–2030
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)